BioSpace News Archive

Biotech Beach

Neoss, Inc. is celebrating the launch of NeoGenix XP™

Following the successful and well-received Allograft line, Neoss is excited to announce the addition of NeoGenix XP™ this autumn to our existing product portfolio.

October 25, 2021
·
2 min read
Genetown

Cedilla Therapeutics Completes $82.6M Series B Financing

Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, announced that it has raised an additional $25 million in an expansion of its Series B financing, bringing the total amount raised to $82.6 million.

October 25, 2021
·
3 min read
Biotech Bay

Silver Bullet Therapeutics Launches OrthoFuzIon® Bone Screw System at DKOU German Congress of Orthopedics and Traumatology

Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced that it is formally launching its antimicrobial OrthoFuzIon Bone Screw System at the DKOU German Congress of Orthopedics and Traumatology on October 26-29 in Berlin.

October 25, 2021
·
4 min read
Speech Therapy Services Market: High Growth Potential for Speech Disorder Segment

Speech therapy is a treatment that helps improve speech impairments and other related disorders. Various methods of the treatment include physical exercises, speech drills, and sound production practice.

October 25, 2021
·
5 min read
ENT Devices Market: Rising prevalence of various ENT disorders to drive the market

Increasing global geriatric population along with rising prevalence of various ear, nose, and throat disorders is a major drivers for the global ENT devices market.

October 25, 2021
·
6 min read
Desmopressin Acetate Market: Rising prevalence of diabetes to drive the market

The global desmopressin acetate market is witnessing a continuously changing market dynamics.

October 25, 2021
·
5 min read
Cryoablation Device Market: Rising incidence of various types of cancer to drive the market

Cryoablation is a treatment in which the irritated nerve is numbed by using localized freezing temperatures.

October 25, 2021
·
6 min read
Sumitomo Heavy Industries Succeeds in Developing a Superconducting Cyclotron for Proton Therapy

Sumitomo Heavy Industries, Ltd. has conducted proton beam acceleration tests on its in-house developed superconducting cyclotron for the next-generation proton therapy system under development and confirmed the generation of a high-intensity proton beam of 1,000 nA.

October 25, 2021
·
2 min read
Drug Development

CytoDyn Announces Treatment of First Patient in Pivotal Phase 3 Trial for Critically Ill COVID-19 Patients in Brazil

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced the treatment of the first patient in its pivotal Phase 3 trial in Brazil for critically ill COVID-19 patients.

October 25, 2021
·
11 min read
Policy

Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of COVID-19 in Adults

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the European Medicines Agency has initiated a rolling review for molnupiravir, an investigational oral antiviral medicine, for the treatment of COVID-19 in adults.

October 25, 2021
·
10 min read